More importantly, our data suggest that the development of a SOCS5-specific inhibitor, an indirect inhibitor of HIF-1α, may be effective in controlling Pringle maneuver-induced tumor micrometastases during liver cancer resection. The gene discussed is SOCS5; the disease is liver cancer.